Add BrightSurf on Google Email

Historical Redlining May Be Linked to Current Kidney Failure

A new study finds that long-term disinvestment in health and wealth resources in historically redlined neighborhoods contributes to a disproportionate rate of kidney failure among Black adults. Redlining, the discriminatory federal housing policy from the 1930s, has been associated with current racial inequities in poor health outcomes.

SourceBoston University School of Public Health·JournalJournal of the American Society of Nephrology·TypeExperimental study·DateJun 29, 2023

Cystatin C shows promise as an additional biomarker to calculate kidney function and stage chronic kidney disease

A study found that cystatin C-based eGFR was strongly correlated with creatinine-based eGFR and that 27% of patients would be classified as having a more severe chronic kidney stage based on cystatin C test results. The use of cystatin C can lead to changes in CKD staging, which can impact clinical management.

SourceBrigham and Women's Hospital·JournalKidney Medicine·TypeObservational study·DateFeb 14, 2023

Large study identifies risk factors in children with chronic kidney disease

Researchers analyzed electronic health record data from over 7.1 million children to identify risk factors associated with a faster decline in kidney function, including disease origin, proteinuria, hypertension, and younger age. The study found that certain attributes are linked to a more rapid decline in kidney function, providing va...

SourceChildren's Hospital of Philadelphia·JournalClinical Journal of the American Society of Nephrology·DateFeb 6, 2023

Follow-up clinic visits with a nephrologist after hospital discharge may improve survival in patients with acute kidney injury

Regular follow-up clinic visits with a nephrologist after hospital discharge significantly reduce mortality risk in patients with acute kidney injury (AKI). This study found that such visits, focusing on cardiovascular disease and kidney complications management, lead to lower mortality rates by 29% compared to standard care.

SourceNational Kidney Foundation·JournalAmerican Journal of Kidney Diseases·DateDec 15, 2022

New onset chronic kidney disease in people with diabetes highest among ethnic, racial minorities

A study published in the New England Journal of Medicine found that new onset CKD rates are higher among Native Hawaiian/Pacific Islander, Black, American Indian/Alaska Native, and Hispanic/Latino populations compared to white persons with diabetes. The rate declined from 8% in 2015-2016 to 6.4% in 2019-2020.

SourceUniversity of California - Los Angeles Health Sciences·JournalNew England Journal of Medicine·TypeData/statistical analysis·DateOct 31, 2022

NKF/TOS urge collaboration, clinical strategies to improve understanding of managing co-existing relationship between obesity, chronic kidney disease

Experts recognize obesity as a prime inducer of CKD and related adverse outcomes, emphasizing the need for bridging common ground between nephrology and obesity medicine. Strategies include recognizing obesity as a chronic disease with targeted treatments and trained clinical extenders to promote effective care.

SourceThe Obesity Society·JournalObesity·DateOct 21, 2022

Kidney disease measures are associated with structural brain damage across different domains of etiology

Reduced kidney function and increased urine albumin excretion are associated with brain volume reduction in regions typically affected by Alzheimer's disease and other dementia etiologies. Cognitive decline is common in patients with kidney disease, and this study provides new insights into the etiology and localization of brain damage.

SourceNational Kidney Foundation·JournalAmerican Journal of Kidney Diseases·DateSep 27, 2022

Quality Improvement Program increases pneumococcal vaccination in adults with advanced kidney disease

A quality improvement program increased pneumococcal vaccination rates from 53% to 70% in adults aged 18-64 years with stage 4 and 5 chronic kidney disease. The intervention, which utilized electronic best practice alerts within the electronic medical record, improved vaccination rates primarily among this high-risk group.

SourceNational Kidney Foundation·JournalAmerican Journal of Kidney Diseases·DateAug 17, 2022

Lumasiran shows efficacy in adults with reduced GFR and primary hyperoxaluria type 1 (PH1)

Lumasiran, an RNA interference therapeutic, has been shown to reduce oxalate levels in patients with primary hyperoxaluria type 1 (PH1) who have relatively preserved kidney function. In the ILLUMINATE-C study, lumasiran resulted in substantial reductions in plasma oxalate with acceptable safety in patients on hemodialysis.

SourceNational Kidney Foundation·JournalAmerican Journal of Kidney Diseases·DateJul 14, 2022

Low-dose lithium may slow kidney aging

Researchers at The University of Toledo found that low-dose lithium acts as a powerful anti-aging agent in the kidneys by blocking GSK3-beta, an enzyme associated with cellular aging. Studies showed improved kidney function and reduced albuminuria in mice and psychiatric patients treated with lithium.

SourceUniversity of Toledo·JournalJournal of Clinical Investigation·TypeExperimental study·DateApr 12, 2022

Henry Ford Health System study finds high mortality associated with acute kidney injury

A study by Henry Ford Health System found that one in four patients who developed acute kidney injury (AKI) die within a year, emphasizing the urgent need for improved treatments. The study analyzed data from over 1.6 million U.S. Veterans hospitalized between 2008 and 2017, providing valuable insights into AKI-associated mortality.

SourceHenry Ford Health·JournalClinical Journal of the American Society of Nephrology·DateFeb 10, 2022

Gene variants increase risk of kidney failure in Black veterans with COVID-19: study

A new study published in JAMA Internal Medicine has found that gene variants increased the risk of acute kidney injury and death in African American veterans hospitalized with COVID-19. The study, which analyzed data from over 850,000 diverse veterans, identified APOL1 variants as a key contributor to this increased risk.

SourceVanderbilt University Medical Center·JournalJAMA Internal Medicine·TypeData/statistical analysis·DateFeb 10, 2022

Little test, big impact: dipstick screening for hematuria

Researchers in Japan evaluated the cost-effectiveness of adding dipstick hematuria screening to a mass health check-up program. The study found that including routine testing for hematuria would promote early detection and treatment, leading to cost savings and improved patient outcomes. This cost-effective approach has the potential t...

SourceUniversity of Tsukuba·JournalClinical and Experimental Nephrology·DateFeb 3, 2022